• Explore /
  • Poster
  • / Analysis of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with carboplatin-paclitaxel after multiple lines of treatment.

Analysis of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with carboplatin-paclitaxel after multiple lines of treatment.

Abstract Poster

Authors

null

Elisa María Fernández Pérez

Hospital Universitario Virgen de Valme, Sevilla, Spain

Elisa María Fernández Pérez , Isabel Beltrán Guerra , Adrian Sánchez Vegas , Carlos Enrique Robles , Gloria Lourenzo Aguilera , Marta Fernández Carcaño , Carlos Ayala De Miguel , Sebastián Díaz López , Guillermo García González , Leonid Bachurin , Javier Rico López , Jose Fuentes Pradera , Jeronimo Jimenez Castro , María Rodríguez de la Borbolla , Pilar López Álvarez , María José Gómez Reina , Manuel Chaves Conde Sr., Eva Fernández Parra

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 144)

DOI

10.1200/JCO.2024.42.4_suppl.144

Abstract #

144

Poster Bd #

F15

Abstract Disclosures

Similar Posters

First Author: Elena Castro

First Author: George Slade Mellgard

First Author: Louise Kathleen Kostos

First Author: Cedric Pobel